Nutritional aspects of herbal medicines and their effects on the prevention of COVID-19 in Brazil
DOI:
https://doi.org/10.33448/rsd-v9i7.4940Keywords:
Phytotheraphy; Herbal medicine; COVID-19.Abstract
The recent outbreak of COVID-19 in China was considered a serious public health problem by the World Health Organization (WHO), an examination that there is no vaccine or medicine capable of causing or treating diseases, but it is Chinese medicine with its herbal products, it is recommended to use some herbs to avoid COVID-19, including the oral administration of some of these herbal medicines. The occurrence of COVID-19 has spread worldwide, and cases have been reported in several countries, so the World Health Organization (WHO) declared a pandemic, among the affected countries are China, Italy, Spain, United States and Brazil. This is an integrative review on aspects of the COVID-19 pandemic, appearance, symptoms, and data on herbal medicines related to the prevention of this disease. This review was based on the publications in the PUBMED database with articles from the year 2020. Traditional Chinese medicine has brought hope for prevention and treatment in some research, as it already plays an important role in the treatment of other pathologies. In China, during the outbreak of COVID-19, hospitals specialized in traditional medicine using plants were established. medicinal, in search of a collective and effective treatment, which treated more than 60,000 patients.
References
Adhiraki, Sasmita Poudel, Meng, Sha, Wu, Yu-Ju, Mao, Yu-Ping, Ye, Rui Xue, Wang, Qing-Zhi, Sun, Chang, Sylvia, Sean, Rozelle, Scott, Raat, Hein, Zhou, Huan. (2020). Epidemiology, causes, clinical manifestation and diagnosis, prevention and controlo of coronavírus disease (COVID-19) during the early outbreak period: a scoping review. Infectious diseases of poverty. 9(29), 1-12. https://doi.org/10.1186/s40249-020-00646-x.
Ahn, Dae Gyun, Shin, Hye Jin, Kim, Mi Hwa, Lee, Sunhee, Kim, Hae Soo, Myoung, Jinjong, Kim, Bum Tae, Kim, Seong Jun. (2020). Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19). J. Microbiol. Biotechnol. 30(3), 313-324. https://doi.org/10.4014/jmb.2003.03011
Guo, Yan Rong, Cao, Qing Dong, Hong, Zhong Si, Tan, Yuan Yang, Chen, Shou Deng, Jin, Hong Jun, Tan, Kai Sen, Wang, Den Yun, Yan, Yan. (2020). The origin, transmission and clinical therapies on coronavírus disease 2019 (COVID-19) outbreak – an update on the status. Military Medical Research. 7(11), 1-10. https://doi.org/10.1186/s40779-020-00240-0.
Hernandez, Alfonso, Papadakos, Peter J, Torres, Antoni Herández, Gonzales, Domingo A, Vives, Marc, Ferrando, Carlos, Baeza, J. (2020). Dos terapias conocidas podrían ser efectivas como adyuvantes en el paciente crítico infectado por COVID-19. Revista Española de Anestesiologia y Reanimación. 67(5), 245-252. https://doi.org/10.1016/j.redar.2020.03.004.
Hui Luo, Qiao-Ling, Tang, Ya-xi, Shang, Liang, Shi-bing, Ming, Yang, Robinson, Nicola, Liu, Jian-ping, (2020). Can chinese medicine be used for prevention of corona vírus disease 19 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chinese journal of integrative medicine. 26(4) https://doi.org/10.1007/s11655-020-3192-6.
Jin, Ying Hui, Cai, Lin, Cheng, Zhen-Shun, Cheng, Hong, Deng, Tong, Fan, Yi-Pin, Fang, Cheg, Huang, Di, Huang, Lu-Qi, Huang, Quiao, Han, Yong, Hu, Bo, Hu, Fe, Li, Bing-Hui, Li, Rong, Liang, Ke, Lin, Li-Kai, Luo, Li-Sha, Ma, Jing. et al. (2020). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standart version). Military Medical Research. 7(4), 1-23. https://doi.org/ 10.1186/s40779-020-0233-6
Korean Society of infectious diseases; Korean Society of pediatric infectious diseases; Korean Society of Epidemiology; Korean Society for Antimicrobial therapy; Korean Society for Healthcare-associated infection control and prevention; Korea Centers for disease control and prevention. (2020). Reporto n the epidemiological features of coronavirus disease 2019 9COVID-19) outbreak in the republico of Korea from January 19 to march 2, 2020. J Korean Med Sci. 16(35), 2-11. https://doi.org/10.3346/jkms.2020.35.e112.
Lake, Mary A. (2020). What we know so far: COVID-19 current clinical knowledge and research. Clinical Medicine. 20(2), 124-127. https://doi.org/10.7861/clinmed.2019-coron.
Li, Taisheng, Lu, Hongzhou, Zhang, Wenhong. (2020). Clinical observation and management of COVID-19 patients. Emerging microbes & infections. 9(1), 687-690. https://doi.org/ 10.1080/22221751.2020.1741327.
Li, Yuxi, Liu, Xiabo, Guo, Liuxue; Li, Juan; Zhong, Dongling, Zhang, Yonggang, Clarke, Mike, Jin, Rongjiang. (2020). Traditional chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-analysis. 9(75), 1-6. article crd42020168004.
Lim, Jaegyun, Jeon, Seunghyun, Shin, HyunYoung, Kim, Moon Jung, Seong, Yu Min, Lee, Wang Jun, Choe, Kang Won, Kang, Yu Min, Lee, Baeckseung, Park, Sang Joon. (2020). Case of the index patient who caused tertiary transmissision of coronavirus disease 2019 in Korea: the application of Lopinavir/Ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR. J Korean Med Sci. 17(35), 1-6. https://doi.org/ 10.3346/jkms.2020.35.e79.
McCarty, Mark F, DiNicolatonio, James J. (2020). Nutraceuticals have potential for boosting the type 1 interferon response to DNA viroses including influenza and coronavirus. Progress and cardiovascular diseases. https://doi.org/10.1016/j.pcad.2020.02.007.
Panahi Latif, Amiri Marzieh; Pouy Somaye. (2020). Risks of novel Coronavirus disease (COVID-19) in pregnancy; a narrative review. Archives of Academy Emergency Medicine. 8(1), 1-5. PMC7092922.
Ren, Jun-Lin, Zhang Ai-Hua, Wang, Xi-Jun. (2020). Traditional chinese medicine for COVID-19 treatment. 155. https://doi.org/10.1016/j.phrs.2020.104743.
Shanmugaraj Balamurugan, Siriwattananon Konlovat, Wangkanont Kittikhun, Phoolcharoen Waranjoo. (2020). Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavírus disease-19 (COVID-19). Asian Pacific Journal of Allergy and Imunnology. 38(1), 10-18. https://doi.org/ 10.12932/AP-200220-0773.
Singhal, Tanu. (2020). Rewiew of coronavírus disease 2019 (COVID-19). The indian journal of pediatrics. 87(3), 281-286. https://doi.org/10.1007/s12098-020-03263-6.
Weston Stuart, Frieman Matthew B. (2020). COVID-19: Knowns, Unknows, and Questions. Msphere. 5(2), 203-220. https://doi.org/10.1128/mSphere.00203-20.
Yang Yang, Islam Md Sahidul, Wang Jiu, Li Yuan, Chen Xin. (2020). Traditional chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-Cov-2): A review and perspective. International journal of biological scienses. 16(10), 1708-1717. https://doi.org/10.7150/ijbs.45538.
Yuen Kit-San, Ye Zi-Wei, Fung Sin-Yee, Chan Chi-Ping, Jin Dong-Yan. (2020). SARS-CoV2 and COVID-19: the most important research questions. Cell & Bioscience. 10(40), 1-5. https://doi.org/ 10.1186/s13578-020-00404-4.
Zhang, D.H.; Wu, K.L.; Zhang, X.; Deng, S.Q.; Peng, B. (2020). In sílico screening of chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. Journal of integrative medicine. 18(2), 152-158. https://doi.org/10.1016/j.joim.2020.02.005.
Zhang, R.; Wang, X.; Ni, L.; Di, X.; Ma, B.; Niu, S.; Liu, C.; Reiter, R.J. (2020). Covid-19: Melatonin as a potential adjuvant treatment. Life Scienses. 250. https://doi.org/10.1016/j.lfs.2020.117583
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
